News

News Image
Keithen Drury
Apr 14, 2026 12:30 AM

Palantir's AIP Is Its Secret Growth Weapon. But Is the Stock a Buy?

Palantir's AI Platform (AIP) has driven exceptional growth, turning a $10,000 investment from early 2023 into $206,000. While the company is projected to achieve 62% revenue growth in 2026 and maintains impressive 44% profit margins, the stock trades at 100x forward earnings with most of this growth already priced in. The analyst recommends avoiding the stock due to overvaluation, despite believing the company will continue to thrive operationally.

News Image
Motley Fool Staff
Apr 14, 2026 12:15 AM

Breaking Down Jamie Dimon’s Investing Letter

The Motley Fool discusses Jamie Dimon's annual shareholder letter for JPMorgan Chase, highlighting his warnings about private credit markets and criticism of Basel III regulations. The episode also covers Bill Ackman's latest attempt to acquire Universal Music Group for $60 billion and examines whether following famous investors' stock picks is a viable strategy. Additionally, the hosts analyze covered call ETFs like JEPQ, noting their high yields come with tax headwinds and capped upside potential.

News Image
Reuben Gregg Brewer
Apr 14, 2026 12:15 AM

The Best High-Yield Stocks to Buy With $2,000 Right Now

With the S&P 500 offering only a 1.1% yield amid geopolitical uncertainty, the article recommends Federal Realty and Realty Income as reliable high-yield dividend stocks. Federal Realty, a Dividend King with 58 consecutive annual dividend increases, offers a 4.1% yield and focuses on quality real estate portfolio management. Realty Income, the largest net-lease REIT with 31 years of dividend increases, provides a 5% yield and maintains strong occupancy rates even during recessions.

News Image
Thomas Niel
Apr 13, 2026 11:30 PM

CVS Health Just Got a $13 Billion Reprieve. Here's Why the Stock Could Keep Climbing.

CVS Health received positive news when Medicare finalized a 2.5% payment increase to providers, significantly better than the initially proposed 0.09% increase. This $13 billion boost to insurers like CVS's Aetna unit improves profitability outlook. Trading at 11x forward earnings compared to peers at 15-20x, CVS appears undervalued with potential to reach $90-$100 per share, supported by 3.4% dividend yield and expected earnings growth.

News Image
Eric Volkman
Apr 13, 2026 11:21 PM

Why Palo Alto Networks Stock Popped Powerfully on Monday

Palo Alto Networks stock surged 4.35% on Monday as part of a broader tech sector rally. Goldman Sachs published an analysis suggesting legacy tech companies were oversold, while Piper Sandler analyst Rob Owens reiterated an overweight rating and $265 price target after investor meetings, expressing confidence that the company is well-positioned to benefit from AI integration rather than being disrupted by it.